http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022304968-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39bd6d1db4deaa11c6474864cd66dced
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-231
filingDate 2022-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c669177d982ee5a432ee2b165aa5c072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5e8e76b63c0b13465a2e7b92bad87b6
publicationDate 2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022304968-A1
titleOfInvention Oxidative retinal diseases
abstract Some aspects of the invention provide for a method of treating Wet and/or Dry Age-related Macular Degeneration, Retinitis Pigmentosa, Diabetic Retinopathy, cataracts, and/or Stargardt Disease using polyunsaturated fatty acids which are modified in certain positions to attenuate oxidative damage by Reactive Oxygen Species (ROS) and/or suppress the rate of formation of reactive products and toxic compounds.
priorityDate 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455639262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89965896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458079095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478821577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458079100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458079330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160372304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458079331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451987657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458079332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161776796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455393420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455393465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458079098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455378432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458081025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455393257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454017953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425927167

Total number of triples: 59.